Natraj Proteins Ltd (530119)
🎯 Key Takeaways
- Natraj Proteins Ltd is navigating a volatile recovery phase marked by inconsistent profitability and strategic reinvestment. After sustained losses in H1 FY25, the company returned to profitability in Q3 FY26 but remains in a turnaround stage with uneven execution.
- Revenue grew 66.5% QoQ to ₹31 in Q1FY27.
- ⚠️ 1) Persistent volatility in profitability despite revenue growth, with management not providing formal earnings guidance. 2) Rising leverage coincidin
- Market Cap
- ₹15
- P/E Ratio
- 3.4
- P/B Ratio
- 0.45
- ROE
- 13.4%
- ROCE
- 9.9%
- Debt/Equity
- 1.08
- Promoter
- 41.8%
📖 The Story
Natraj Proteins Ltd is navigating a volatile recovery phase marked by inconsistent profitability and strategic reinvestment. After sustained losses in H1 FY25, the company returned to profitability in Q3 FY26 but remains in a turnaround stage with uneven execution. Management is prioritizing operational stabilization while managing high leverage and capital intensity.
📰 What's Happening
Management highlighted the commissioning of a new solvent extraction plant in Q3 FY26, aimed at improving margin sustainability. A strategic land acquisition in Gujarat was disclosed in the June 2026 filing to support future capacity expansion. Management also emphasized cost rationalization efforts amid intense competitive pressure in the edible oil segment. No major M&A or leadership changes were reported in recent quarters.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue | 27 | 27 | 29 | 19 | 31 |
| Operating Profit | -1 | -1 | 3 | 2 | 3 |
| OPM % | -2.7% | -4.1% | 12.0% | 8.5% | 8.6% |
| Net Profit | -1 | -2 | 3 | 1 | 2 |
| EPS | ₹-3.24 | ₹-4.41 | ₹7.72 | ₹2.96 | ₹5.62 |
Revenue has shown sequential improvement from ₹27 crore in Q2 FY25 to ₹31 crore in Q1 FY26, but profitability remains erratic — with operating losses in two of the last five quarters. The sharp swing to ₹3 crore operating profit in Q1 FY26 contrasts with a -₹1 crore in Q4 FY25, indicating progress but not yet consistent earnings quality. Management attributes margin recovery to volume gains and operational efficiencies, though scale remains limited.
🔮 Management Outlook & What's Next
In the Q1 FY26 earnings call, management expressed confidence in sustaining margin improvement through better product mix and supply chain optimization, while acknowledging the need for continued capex discipline. They reiterated plans to expand in high-growth regional markets but provided no formal revenue or margin guidance. No dividend was recommended, reflecting capital retention priorities.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 4 | 4 | 4 | 4 |
| Reserves | 28 | 27 | 30 | 26 |
| Borrowings | 23 | 17 | 36 | 24 |
| Total Liabilities | 59 | 52 | 76 | 57 |
| Fixed Assets | 5 | 5 | 6 | 5 |
| Investments | 0 | 0 | 0 | 0 |
| Total Assets | 59 | 52 | 76 | 57 |
The balance sheet shows a significant rise in borrowings from ₹24 crore to ₹36 crore YoY, coinciding with asset growth from ₹57 crore to ₹76 crore. This suggests ongoing capital investment, likely tied to expansion initiatives. Despite profitability returning, leverage remains elevated, with net debt increasing and equity buffers thin, raising concerns about financial resilience if operating performance falters.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2025 | Mar 2026 |
|---|---|---|
| Operating | +22 | -14 |
| Investing | -2 | +3 |
| Financing | -20 | +11 |
| Net Cash Flow | -1 | +0 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 42.1% | 41.8% | 41.8% | 41.8% |
| FII | 0.0% | 0.0% | 0.0% | 0.0% |
| DII | 1.9% | 1.9% | 1.9% | 1.9% |
| Public | 50.7% | 51.0% | 50.9% | 50.9% |
| # Shareholders | 3,140 | 3,163 | 3,194 | 3,099 |
Promoter holding has slightly declined from 42.14% to 41.82% over four quarters, with no FII or DII activity reported in recent quarters. The growing number of public shareholders indicates retail interest but limited institutional engagement. No pledging or significant stake sales were disclosed, suggesting confidence from promoters, but the lack of institutional inflows reflects cautious investor sentiment.
⚖️ Peer Comparison — Edible Oil
🔗 Peer Stock Analyses
⚠️ Risk Factors
1) Persistent volatility in profitability despite revenue growth, with management not providing formal earnings guidance. 2) Rising leverage coinciding with expansion, creating execution and financial risk. 3) Low institutional ownership and lack of FII interest may limit upside momentum. 4) High sensitivity to crude palm oil prices and commodity volatility, which management has not hedged or mitigated in disclosures.
📋 Recent Filings
- 🟡 Board Meeting2026-09-29Natraj Proteins held its 35th Annual General Meeting on 29 September 2026 via video conference, with all directors and key officers present, quorum me…
- 🟡 Board Meeting2026-09-29Natraj Proteins Ltd announced the re-appointment of Shri Sharad Kumar Jain as Whole Time Director and Executive Director effective 1st October 2026 fo…
- 🟡 Board Meeting2026-09-29Natraj Proteins Ltd shareholders approved four resolutions at its 35th AGM on September 29, 2026, including adoption of audited financial statements f…
- Announcement2026-09-28Natraj Proteins Ltd announced a trading window closure effective 1 October 2026 through completion of 48 hours after quarterly results for September 2…
- 🔴 annual report2026-09-09Natraj Proteins Limited dispatched letters to shareholders who have not registered their email addresses, informing them that the 35th Annual Report a…
- 🔴 annual report2026-09-07Natraj Proteins Limited submitted its 35th Annual Report for FY 2025-26 to BSE on September 7, 2026, covering the year ended March 31, 2026. The repor…
- 🟡 Board Meeting2026-09-07Natraj Proteins Ltd announced its 35th Annual General Meeting will be held on 29 September 2026 at 2:00 PM via video conferencing, with the registered…
- 🟡 Board Meeting2026-09-04Natraj Proteins Limited announced remote e-voting facilities for its 35th Annual General Meeting scheduled for Tuesday, 29th September 2026, enabling …
- 🟡 Board Meeting2026-09-04Natraj Proteins announced book closure from September 23 to 29, 2026, to facilitate its 35th Annual General Meeting scheduled for September 29, 2026 a…
🧠 Analyst's Read
Natraj Proteins is in a fragile turnaround, where margin gains and debt management will determine sustainability. Investors should watch for consistent operational improvements and clearer capital allocation signals in upcoming filings.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-30.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts for your stocks — summarized by AI daily
Set up your AI Radar — pick stocks, get daily email summaries of new filings.
Set up AI Radar — FreeFree account · 2 AI queries/day